December 27, 2022 is the deadline date by which employers who maintain group health plans must report certain prescription drug and medical spending information to
On August 25, 2022, the Securities and Exchange Commission (the “SEC”) adopted final rules on pay versus performance disclosure under Section 14(i) of the Securities
On August 24, 2022, the Securities and Exchange Commission (the “SEC”) released its draft strategic plan for fiscal years 2022 to 2026 (the “Strategic Plan”).
New York held its second of two primary elections of the 2022 cycle yesterday as a result of a lawsuit filed related to the redistricting
On Wednesday, August 24, 2022, the Office of Cannabis Management (“OCM”) announced the number of Conditional Adult-Use Retail Dispensary (“CAURD”) licenses that will be available
On Thursday, August 11, 2022, the Office of Cannabis Management (“OCM”) announced that the application period for Conditional Adult-Use Retail Dispensary (“CAURD”) licenses will open
On August 3, 2022, the Internal Revenue Service (“IRS”) issued Notice 2022-33 (the “Notice”), providing welcome relief to plan administrators and plan sponsors by extending
Have you ever wondered, “How do I redact information from agreements filed with the SEC?” Whether it’s something obvious, like a home address or social
On May 3, 2022, the Securities and Exchange Commission’s (the “SEC”) Division of Corporation Finance (the “Division”) released a sample comment letter detailing potential disclosure
On May 25, 2022, the Securities and Exchange Commission (the “SEC”) proposed rule and form amendments under both the Investment Advisers Act of 1940, as
